Addressing Apoptosis to Tumor Zip Codes.

In the current issue of Cancer, Pasqualini and colleagues report on a study in which they target prostatic tumor vasculature signatures with an apoptosis‐inducing, peptidomimetic drug. The authors of this editorial place this vascular‐targeting discovery into a broader clinical context while focusing on opportunities and challenges in implementing it further. [ABSTRACT FROM AUTHOR]